Pain and Spasticity After Spinal Cord Injury
- 1 December 2001
- journal article
- review article
- Published by Wolters Kluwer Health in Spine
- Vol. 26 (Supplement) , S146-S160
- https://doi.org/10.1097/00007632-200112151-00024
Abstract
A comprehensive survey of literature on the proposed mechanisms and treatment of pain and spasticity after spinal cord injury (SCI) was completed. To define the current understanding of these entities and to review various treatment options. The neurophysiologic basis of spasticity after SCI is well established. The mechanism of neuropathic pain after SCI remains conjectural, although considerable new data, much of it from animal models, now add to our understanding of this condition. A comprehensive search and review of the published literature was undertaken. Treatment options for spasticity are effective and include oral medication (baclofen, tizanidine), intrathecal baclofen, and rarely, surgical rhizotomy or myelotomy. Selected patients with post-SCI pain can respond to surgical myelotomy (DREZ lesions) or intrathecal agents (e.g., morphine + clonidine), but the majority continue to suffer. Medical and surgical treatments for spasticity are established and highly successful. Management of post-SCI pain remains a clinical challenge, as there is no uniformly successful medical or surgical treatment.Keywords
This publication has 129 references indexed in Scilit:
- A DOUBLE-BLIND TRIAL WITH BACLOFEN (LIORESAL®) AND DIAZEPAM IN SPASTICITY DUE TO MULTIPLE SCLEROSISActa Neurologica Scandinavica, 2009
- NMDA-Receptor Antagonists in Neuropathic Pain: Experimental Methods to Clinical TrialsJournal of Pain and Symptom Management, 2000
- DREZ Coagulations for Deafferentation Pain Related to Spinal and Peripheral Nerve Lesions: Indication and Results of 79 Consecutive ProceduresStereotactic and Functional Neurosurgery, 1997
- Effects of intrathecal baclofen on chronic spinal cord injury painJournal of Pain and Symptom Management, 1996
- 4-Aminopyridine-Sensitive Neurologic Deficits in Patients with Spinal Cord InjuryJournal of Neurotrauma, 1994
- Treatment of spasticity with botulinum toxin: A double‐blind studyAnnals of Neurology, 1990
- Intrathecal Baclofen for Severe Spinal SpasticityNew England Journal of Medicine, 1989
- Experience with spinal cord stimulation (SCS) in the management of chronic pain in a traumatic transverse lesion syndromeNeurosurgical Review, 1989
- Multi-centre, double-blind trial of a novel antispastic agent, tizanidine, in spasticity associated with multiple sclerosisCurrent Medical Research and Opinion, 1988
- Selenium: A Case for Its Essentiality in ManNew England Journal of Medicine, 1981